pillbase.ru

RELENZA

Active substance: zanamivir

POWDER · ZANAMIVIR 5 mg/1

United StatesActive

Marketing holder: A-S Medication Solutions

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Реленза
    порошок для ингаляций дозированный, 5 мг/доза, 20 мг (4 дозы) (original in Russian, GRLS)
    ЛП-№(006063)-(РГ-RU)
    АО "ГлаксоСмитКляйн Трейдинг"
  • Реленза
    порошок для ингаляций дозированный, 5 мг/доза, 20 мг (4 дозы) (original in Russian, GRLS)
    ЛСР-000095
    АО "ГлаксоСмитКляйн Трейдинг"
EU 1
  • Dectova
    zanamivir
    EMEA/H/C/004102
    GlaxoSmithKline Trading Services Limited
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-75d0-7712-92a4-b28870f7f659,01a120c4-0a18-7dda-baea-4699f4646505;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-5e3f-7c12-935e-6440722a3afa,01a1209a-ec00-7a6c-b3d0-dad64dc0a206;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50090-8016
Registration status
Active
Dispensing
Prescription only
Route
RESPIRATORY (INHALATION)
Sources
  • product · openFDA NDC · 50090-8016 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50090-8016 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50090-8016 · Verified 2026-10-09 · open in source